HBV latest

[thanks2018]

Please see the below link.


First HBV Patient Dosed in Phase IIa Clinical Trial of ASC22, a Subcutaneously Administered PD-L1 Antibody

https://www.prnewswire.com/news-releases/first-hbv-patient-dosed-in-phase-iia-clinical-trial-of-asc22-a-subcutaneously-administered-pd-l1-antibody-301112931.html

[stef2011]

we have to wait and see if it is better than nivolumab that had good results already too but probably too cheap....
the best thing would be to check cccdna levels by biopsy to be sure immune response to hbv will not destroy the liver